Skip to content
Psychiatrist.com Logo
  • JCP
  • PCC
  • News
  • CME
  • About
  • Authors & Reviewers
  • Sign In
  • Subscribe
Advanced Search

Menu

  • JCP
  • PCC
  • News
  • CME
  • About
  • Authors & Reviewers
  • Sign In
  • Subscribe
Sign in Subscribe

Clinical Topics

View All
  • Addiction
  • ADHD
  • Alzheimer’s Disease
  • Anxiety
  • Bipolar Disorder
  • Depression
  • Movement Disorders
  • Neurology
  • OCD
  • Psychopharmacology
  • PTSD and Trauma
  • Schizophrenia/Schizoaffective Disorders
  • Sleep
  • Tardive Dyskinesia
  • View All

Collections

View All
  • Academic Highlights
  • Auvelity: Information from Industry
  • Banner Alzheimer’s Institute
  • Clinical & Practical Psychopharmacology
  • Early Career Psychiatrists
  • Focus on Childhood and Adolescent Mental Health
  • Focus on Geriatric Psychiatry
  • Focus on Psychotherapy
  • Focus on Suicide
  • Focus on Psychosis
  • Focus on Women’s Mental Health
  • Rounds in the General Hospital
  • UZEDY: Information from Industry
  • View All
Back to top Open menu arrow
Download PDF Reprints
No sections available

The Primary
Care Companionfor CNS Disorders

Free access
Suicide

Letter to the Editor October 15, 2008

Low Cholesterol, Delinquency, and Suicidality

Luca Mascitelli, M.D.; Francesca Pezzetta, M.D.; Mark R. Goldstein, M.D.

Prim Care Companion J Clin Psychiatry 2008;10(5):413-414

Article Abstract

Letter to the Editor

Low Cholesterol, Delinquincy, and Suicidality

About the Authors

  • Luca Mascitelli, M.D.
    View full profile
  • Francesca Pezzetta, M.D.
    View full profile
  • Mark R. Goldstein, M.D.
    View full profile
Download Free PDF

This PDF is free for all visitors!

Announcement: The Journal of Clinical Psychiatry launches a new podcast. Click to learn more.

Related JCP Articles

Factors Associated with Revisiting the Emergency Department due to Suicidal Behavior in Children and Adolescents Psychiatric Hospitalization and Suicide Attempts in Healthcare Professionals Precision Medicine for Suicide Prevention: It’s Time to Take the Next Step

Related PCC Articles

Tetrabenazine-Induced Suicidality Comorbidities Obscure Autism Diagnosis Impact of Patient Suicide on Mental Health Professionals
Figure—Magazine cover highlights articles on suicide attempts, family support, impulsivity, grief, and bipolar disorder care.

Vol 28 • 2026 • Number 1

Read the Current Issue

Original Research

Suicidal Mental Imagery in Suicide Attempters

Original Research

Family Support for Patients With Substance Use Disorders

Rounds in the General Hospital

Diagnosing and Treating Impulsivity

Rounds in the General Hospital

Managing Grief and Bereavement

Brief Report

Measurement-Based Care for Bipolar Disorder

Rounds in the General Hospital

Treatment and Referral for AUD in Primary Care

View current Issue

Related Articles

JCP
Daridorexant: Caution Is Needed About Suicidal Risk in Depressed Patients With Insomnia—Reply to Palagini et al
Letter to the Editor

Daridorexant: Caution Is Needed About Suicidal Risk in Depressed Patients With Insomnia—Reply to Palagini et al

July 3, 2023

Bénédicte Nobile, PharmD, PhD, and Philippe Courtet, MD, PhD, continue the discussion of potentially increased suicidal risk with daridorexant, a new hypnotic.
Bénédicte Nobile, Philippe Courtet
JCP
Aggravation of Suicide Risk With Daridorexant: Currently Not Enough Data to Show a Link
Letter to the Editor

Aggravation of Suicide Risk With Daridorexant: Currently Not Enough Data to Show a Link

July 3, 2023

Palagini and colleagues comment on a recent letter that suggested a role for daridorexant, a new hypnotic, in increasing suicide risk.
Laura Palagini, Pierre A. Geoffroy, Jean Arthur Micoulaud-Franchi, et al
JCP
Possible Suicidal Risk With Daridorexant
Letter to the Editor

Possible Suicidal Risk With Daridorexant

December 7, 2022

Instructions for use of the new anti-insomnia medication daridorexant mention cautious use in patients with history of suicidal behavior. This letter explores the factors that underlie this recommendation for...
Bénédicte Nobile, Emilie Olié, Philippe Courtet

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders

ELSEWHERE:

  • ABOUT
  • ADVERTISERS
  • MEDIA RELATIONS
  • REPRINTS & PERMISSIONS
  • CONTACT US
  • CUSTOMER SUPPORT

FOLLOW US:

  • X
  • FACEBOOK
  • INSTAGRAM
  • LINKEDIN
  • THREADS
  • BLUESKY
  • SIGN IN

  • JOIN THE EMAIL LIST


SUBSCRIBE NOW
An image of the Psychiatrist.com logo mark
  • Privacy Policy
  • Terms of Use
  • Physicians Postgraduate Press, Inc.
  • JCP ISSN: Online 1555-2101, Print 0160-6689
  • PCC ISSN: Online 2155-7780, Print 2155-7772
  • MedFair.com US Patent No. 684794
  • © Copyright 2026 | Physicians Postgraduate Press, Inc. | LifeLong Learning For Clinicians
  • Sitemap